Abnex is a privately owned Biotechnology R&D company.  We are dedicated to the discovery and development of antibody-based next-generation therapy for human grievous diseases, including cancers, infectious & inflammatory diseases, and neurodegenerative conditions.  Abnex is founded and managed by the experts in Biopharmaceutical and Biomedical Research & Development. The company is located in the heart of Silicon Valley, California. We have expertise in Antibody Engineering, Bioproduction, Medicinal Chemistry, Pharmacology, Biochemistry, Molecular & Cell Biology, Drug Discovery & Development, Hematology & Oncology, Immunology, and Neuroscience. We have developed a number of innovative technologies and biopharmaceutical projects that subsequently are licensed to our development partners or incorporated into our portfolio companies.  We also provide consulting services for M&A and investment in Biotechnology.